People · Operator
Named in public records as an officer, director or promoter · active 2009–2018 · Biotech, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Transplant Genomics Inc. | — | Biotech | Series A | $20.6M | $288.4M | 2015 |
| Numetric, Inc. | — | Other Technology | Series A | $19.9M | $137.3M | 2017 |
| NextPage, Inc. | — | Other Technology | Seed | $2.4M | $58.4M | 2009 |
Darren Lee at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Darren Lee on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Lee | 1 | 15 |
| Greg Butterfield | 1 | 7 |
| Jay Venkatesan | 1 | 5 |
| Peter Lewis | 1 | 4 |
| Nicolas Wittenborn | 1 | 4 |
| Vinny Pujji | 1 | 4 |
| Stanley Rose | 1 | 4 |
| DANIEL SOLOMON | 1 | 3 |
| Robert Sweeney | 1 | 2 |
| Anthony Bettencourt | 1 | 2 |
| Brett Jensen | 1 | 1 |
| Nate Bowler | 1 | 1 |
| Ryan Hemingway | 1 | 1 |
| John Guymon | 1 | 1 |
| Karl Sweeney | 1 | 1 |
| David Kravitz | 1 | 1 |
| Chris O'Connor | 1 | 1 |
| Craig Shields | 1 | 1 |
| James Seeley | 1 | 1 |
| Wayne Nelson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.